Celldex Therapeutics | Eiendeler



Assets Endring Dato
AbbVie USD 135.16B 8.26B 2024-12
Amgen USD 91.84B 956M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Celldex Therapeutics USD 792.34M 30.84M 2024-12
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12



Celldex Therapeutics Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.